Schedule 13G ownership disclosure
BOLT BIOTHERAPEUTICS INC
Common Stock, par value $0.00001 per share · CUSIP: 097702203
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vivo Capital Fund VIII, L.P.
Shares: 0.00 · Class: 0%
- Vivo Capital Surplus Fund VIII, L.P.
Shares: 0.00 · Class: 0%
- Vivo Capital VIII, LLC
Shares: 0.00 · Class: 0%
- Vivo Panda Fund, L.P.
Shares: 72,414.00 · Class: 3.8%
- Vivo Panda, LLC
Shares: 72,414.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-016669
- Form type
- SCHEDULE 13G/A
- Filer
- Bolt Biotherapeutics, Inc.
- CIK
- CIK 1641281
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership